1. Home
  2. FSI vs MNOV Comparison

FSI vs MNOV Comparison

Compare FSI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

N/A

Current Price

$5.36

Market Cap

67.8M

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.42

Market Cap

66.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
MNOV
Founded
1991
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.8M
66.9M
IPO Year
2000
2004

Fundamental Metrics

Financial Performance
Metric
FSI
MNOV
Price
$5.36
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
13.0K
52.1K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
1.84%
N/A
EPS Growth
9.09
N/A
EPS
0.09
N/A
Revenue
$15,494,325.00
$2,360,807.00
Revenue This Year
$4.11
N/A
Revenue Next Year
$58.09
N/A
P/E Ratio
$60.44
N/A
Revenue Growth
N/A
194.15
52 Week Low
$3.50
$1.17
52 Week High
$11.48
$1.96

Technical Indicators

Market Signals
Indicator
FSI
MNOV
Relative Strength Index (RSI) 47.64 48.59
Support Level $5.21 $1.40
Resistance Level $5.47 $1.43
Average True Range (ATR) 0.22 0.06
MACD 0.01 0.00
Stochastic Oscillator 35.10 29.01

Price Performance

Historical Comparison
FSI
MNOV

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: